Targeting dendritic cells with TLR-2 ligand–coated nanoparticles loaded with Mycobacterium tuberculosis epitope induce antituberculosis immunity
Open Access
- 15 October 2022
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 298 (12) , 102596
Abstract
No abstract availableKeywords
Funding Information
- Department of Science and Technology, Ministry of Science and Technology, India
- Council of Scientific and Industrial Research, India
- Department of Biotechnology, Ministry of Science and Technology, India
- Anusandhan National Research Foundation
- Ministry of Education, India
This publication has 61 references indexed in Scilit:
- Interleukin-17-dependent CXCL13 mediates mucosal vaccine–induced immunity against tuberculosisMucosal Immunology, 2013
- Preparation, characterization and in vitro release study of carvacrol-loaded chitosan nanoparticlesColloids and Surfaces B: Biointerfaces, 2011
- Effects of the TLR2 Agonists MALP-2 and Pam3Cys in Isolated Mouse LungsPLOS ONE, 2010
- Toll‐like receptor 2 agonist Pam3CSK4 enhances the induction of antigen‐specific tolerance via the sublingual routeClinical & Experimental Allergy, 2008
- Tumor Necrosis Factor and TuberculosisJournal of Investigative Dermatology Symposium Proceedings, 2007
- More than one reason to rethink the use of peptides in vaccine designNature Reviews Drug Discovery, 2007
- Vaccine adjuvants revisitedVaccine, 2007
- IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challengeNature Immunology, 2007
- Interleukin 12p40 is required for dendritic cell migration and T cell priming afterMycobacterium tuberculosisinfectionJournal of Experimental Medicine, 2006
- Chitosan nanoparticles as delivery systems for doxorubicinJournal of Controlled Release, 2001